AroCell poster presentations at 2017 NCRI Cancer Conference

Welcome to stop by and discuss AroCell’s TK 210 ELISA poster presentations!

When: Session A, Sunday Nov 5th – Monday November 6th
Where: Hall 2:

  • AroCell TK 210 ELISA may complement pro PSA and the prostate health index in differentiating non-cancerous from cancerous conditions in prostate disease:
    Poster board 39 ID 1385
  • Novel method for studying the in-vitro effects of anti-cancer agents: the assay of thymidine kinase 1 (TK1) in cell culture utilising AroCell TK 210 ELISA
    Poster board 40 and ID 1387

AroCell’s representatives Kiran Jagarlamudi and Martin Shaw look forward to meeting you to discuss these and any other research interests that you may have.